CEACAM5 and neoplasm: In general, we used several human tumor cell lines to establish animal models and confirmed that rhIL‐12 can increase the anti‐tumor activity of CEA‐CAR‐T cells and the combination use showed significantly better anti‐tumor activity than conventional CEA‐CAR‐T cells.